Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Efficacy of Electroacupuncture Combined With PD-1 Inhibitor in the Treatment of ECOG2 Advanced Non-small Cell Lung Cancer

NCT07239661 is registered in ClinicalTrials.gov with Kong Fanming as lead sponsor.

NCT NCT07239661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07239661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Efficacy of Electroacupuncture Combined With PD-1 Inhibitor in the Treatment of ECOG2 Advanced Non-small Cell Lung Cancer
Lead sponsor
Kong Fanming
Phase
Not applicable
Overall status
Recruiting
Start date
November 30, 2025
Completion date
December 31, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ecog ps 2 points, electroacupuncture, non-small cell lung cancer, pd-1 inhibitors